Primary Cutaneous Nocardiosis in a Patient Taking Adalimumab Therapy for Crohn’s Disease

Authors

  • Madhav Desai, MBBS University of Kansas Medical Center, Kansas City, KS, Department of Internal Medicine
  • Muhammad Imran, M.D. University of Kansas Medical Center, Kansas City, KS, Department of Internal Medicine; Division of Allergy, Clinical Immunology and Rheumatology
  • Ayesha Irum Army Medical College, Rawalpindi, Pakistan
  • Julian Magadan III, M.D. University of Kansas Medical Center, Kansas City, KS, Department of Internal Medicine; Division of Allergy, Clinical Immunology and Rheumatology

DOI:

https://doi.org/10.17161/kjm.v10i1.8644

Keywords:

nocardia infections, adalimumab, Crohn’s disease

Metrics

File downloads
356
Jan 2019Jul 2019Jan 2020Jul 2020Jan 2021Jul 2021Jan 2022Jul 2022Jan 2023Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 20268
|

Downloads

Published

2019-01-14

Issue

Vol. 10 No. 1 (2017)

Section

Case Reports

License

All articles in the Kansas Journal of Medicine are licensed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0). 

 

How to Cite

Desai, M., Imran, M., Irum, A., & Magadan III, J. (2019). Primary Cutaneous Nocardiosis in a Patient Taking Adalimumab Therapy for Crohn’s Disease. Kansas Journal of Medicine, 10(1), 20-21. https://doi.org/10.17161/kjm.v10i1.8644